145 related articles for article (PubMed ID: 6305033)
21. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
22. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
23. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
24. [Breast lobular carcinoma in situ: diagnosis and evolution].
Espié M; Hocini H; Cuvier C; Giacchetti S; Bourstyn E; de Roquancourt A
Gynecol Obstet Fertil; 2005 Dec; 33(12):964-9. PubMed ID: 16324870
[TBL] [Abstract][Full Text] [Related]
25. [Relation between dysplasias, benign breast tumors and cancer of the breast. Retrospective study in a group of 735 patients].
Badellino F; Santoro L; Volterrani P; Trabucco A; Tardy A
Cancro; 1974; 27(5):263-70. PubMed ID: 4376974
[No Abstract] [Full Text] [Related]
26. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
27. Incidence and kinetics of distant metastases in patients with operable breast cancer.
Kryj M; Maciejewski B; Withers HR; Taylor JM
Neoplasma; 1997; 44(1):3-11. PubMed ID: 9201274
[TBL] [Abstract][Full Text] [Related]
28. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
30. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L
J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071
[TBL] [Abstract][Full Text] [Related]
31. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
Bodian CA; Perzin KH; Lattes R
Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
[TBL] [Abstract][Full Text] [Related]
32. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
[TBL] [Abstract][Full Text] [Related]
33. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
34. Cancer of the second breast.
Donegan WL; Spratt JS
Major Probl Clin Surg; 1979; 5():464-83. PubMed ID: 222971
[No Abstract] [Full Text] [Related]
35. Risk of subsequent invasive breast cancer after breast carcinoma in situ.
Wärnberg F; Yuen J; Holmberg L
Lancet; 2000 Feb; 355(9205):724-5. PubMed ID: 10703809
[TBL] [Abstract][Full Text] [Related]
36. The Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999.
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL; Pressman PI
Hum Pathol; 2000 Feb; 31(2):131-9. PubMed ID: 10685626
[No Abstract] [Full Text] [Related]
37. Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening.
Spratt JS; Greenberg RA; Heuser LS
Cancer Res; 1986 Feb; 46(2):970-4. PubMed ID: 3940657
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.
Lakhani SR
Breast Cancer Res; 2003; 5(5):248-9. PubMed ID: 12927033
[No Abstract] [Full Text] [Related]
39. Diagnostic drift in the reporting of cancer incidence.
Bailar JC
J Natl Cancer Inst; 1998 Jun; 90(11):863-4. PubMed ID: 9625178
[No Abstract] [Full Text] [Related]
40. Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist?
Calhoun BC; Livasy CA
Arch Pathol Lab Med; 2014 Nov; 138(11):1428-31. PubMed ID: 24628451
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
